Avanos Medical (NYSE: AVNS), which rebranded from Halyard Health last June, said today that it won FDA 510(k) clearance for its ON-Q* with Bolus pump drug infusion device.
The Alpharetta, Ga.-based company said that the new ON-Q* with Bolus system features improvements to improve ease of use and reduce postoperative opioid use for pain management.
The newly cleared device includes customized controls for patients recovering from from post-surgical pain through the delivery of continuous, non-opioid medication to the surgical site or peripheral nerves for up to five days.
“The changes we have made to the ON-Q* Bolus pump are a direct result of the feedback we heard from our customers. Non-opioid approaches to pain management continue to be an important issue in the healthcare industry, particularly in light of the opioid crisis. As a leader in non-opioid treatment for acute pain, we are committed to continuously improving our ON-Q* pumps to deliver increased quality of life and satisfaction to all patients,” CEO Joe Woody said in a press release.
